Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
37 hedge funds and large institutions have $13.6M invested in Checkpoint Therapeutics in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 8 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
0.14% less ownership
Funds ownership: 1.91% → 1.77% (-0.14%)
8% less funds holding
Funds holding: 40 → 37 (-3)
18% less capital invested
Capital invested by funds: $16.6M → $13.6M (-$2.94M)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$545K |
| 2 |
State Street
Boston,
Massachusetts
|
+$158K |
| 3 |
PAS
Park Avenue Securities
New York
|
+$148K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$107K |
| 5 |
Squarepoint
New York
|
+$54.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$810K |
| 2 |
Millennium Management
New York
|
-$124K |
| 3 |
Jane Street
New York
|
-$95K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$90.5K |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$51K |
CKPT Hedge Fund Activity: Q3 2019 in Review
37 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q3 2019, worth a combined $13.6M — down 18% from $16.6M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CKPT and 5 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 15 added.
The largest buyer was Northern Trust, adding an estimated $545K. The largest seller was BlackRock, cutting an estimated $810K.
- 37 institutional investors held Checkpoint Therapeutics (CKPT) as of Q3 2019, down from 40 in Q2 2019.
- Funds reported $13.6M of Checkpoint Therapeutics stock for Q3 2019, down 18% quarter-over-quarter.
- 5 funds opened new Checkpoint Therapeutics positions in Q3 2019 and 8 closed out, a net change of -3 holders.
- The largest Checkpoint Therapeutics buyer in Q3 2019 was Northern Trust, an estimated $545K added.
- The largest Checkpoint Therapeutics seller in Q3 2019 was BlackRock, an estimated $810K sold.
Based on aggregated 13F filings for Q3 2019.